A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist
暂无分享,去创建一个
A. Feeney | D. Nutt | A. Lingford-Hughes | S. Wilson | D. J. Nutt | A. Lingford-Hughes | S. J. Wilson | P. G. Grasby | A. Feeney | P. Grasby
[1] D. Nutt,et al. Pharmacology of saccadic eye movements in man , 1991, Psychopharmacology.
[2] Alan Bateson. Pagoclone Indevus. , 2003, Current opinion in investigational drugs.
[3] D. Nutt,et al. Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder , 2001, Journal of psychopharmacology.
[4] V J Cunningham,et al. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. , 1998, Archives of general psychiatry.
[5] D. Nutt,et al. Benzodiazepine Site Pharmacokinetic/Pharmacodynamic Quantification in Man: Direct Measurement of Drug Occupancy and Effects on the Human Brain In Vivo , 1996, Neuropharmacology.
[6] J. Baron,et al. Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomography. , 1996, European journal of pharmacology.
[7] J. Stutzmann,et al. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent. , 1993, The Journal of pharmacology and experimental therapeutics.
[8] E. Sybirska,et al. [123I]Iomazenil spect imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain , 1993, Neuropharmacology.
[9] W. Haefely,et al. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. , 1992, The Journal of pharmacology and experimental therapeutics.
[10] D. Nutt,et al. Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. , 1991, Psychopharmacology.